Apexigen
Biopharmaceutical product development company developing products to address life-threatening and difficult to treat diseases. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
$16m (Public information from May 2023)
Share price
$0.3851 APGN
Burlingame California (HQ)
Authorizing premium user...